Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Lancet (London, England)
|
November 6, 2007
Cannabis and psychosis
O Schulte-Herbrüggen, M C Jockers-Scherübl
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 3, 2004
State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations
U E Lang, M C Jockers-Scherübl, R Hellweg
Lancet (London, England)
|
April 6, 1996
Is nerve growth factor a serum marker for neurological and psychiatric complications in Behcet's disease?
M C Jockers-Scherübl, C C Zouboulis, F Boegner, et al.
European Journal of Biochemistry
|
March 15, 1989
Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds
M C Jockers-Scherübl, R H Schirmer, R L Krauth-Siegel
Pharmacopsychiatry
|
February 3, 2006
Massive creatine kinase elevations with quetiapine: report of two cases
J P Klein, U Fiedler, H Appel, et al.
Current Medicinal Chemistry
|
September 28, 2007
Neurotrophic factors--a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?
O Schulte-Herbrüggen, A Braun, S Rochlitzer, et al.
Biochemical Society Transactions
|
April 1, 1989
NADPH-dependent disulphide reductases
R L Krauth-Siegel, M C Jockers-Scherübl, K Becker, et al.
Pharmacopsychiatry
|
August 19, 2007
Electroconvulsive monotherapy in confusion psychosis: a potential standard regimen?
A H Neuhaus, A Luborzewski, C Opgen-Rhein, et al.
Pharmacopsychiatry
|
December 13, 2005
Electroconvulsive monotherapy in the treatment of acute confusion psychosis. A case report
A H Neuhaus, J Katchanov, C Opgen-Rhein, et al.
International Clinical Psychopharmacology
|
December 17, 2004
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study
M C Jockers-Scherübl, A Bauer, F Godemann, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Lancet (London, England)
|
November 6, 2007
Cannabis and psychosis
O Schulte-Herbrüggen, M C Jockers-Scherübl
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 3, 2004
State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations
U E Lang, M C Jockers-Scherübl, R Hellweg
Lancet (London, England)
|
April 6, 1996
Is nerve growth factor a serum marker for neurological and psychiatric complications in Behcet's disease?
M C Jockers-Scherübl, C C Zouboulis, F Boegner, et al.
European Journal of Biochemistry
|
March 15, 1989
Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds
M C Jockers-Scherübl, R H Schirmer, R L Krauth-Siegel
Pharmacopsychiatry
|
February 3, 2006
Massive creatine kinase elevations with quetiapine: report of two cases
J P Klein, U Fiedler, H Appel, et al.
Current Medicinal Chemistry
|
September 28, 2007
Neurotrophic factors--a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?
O Schulte-Herbrüggen, A Braun, S Rochlitzer, et al.
Biochemical Society Transactions
|
April 1, 1989
NADPH-dependent disulphide reductases
R L Krauth-Siegel, M C Jockers-Scherübl, K Becker, et al.
Pharmacopsychiatry
|
August 19, 2007
Electroconvulsive monotherapy in confusion psychosis: a potential standard regimen?
A H Neuhaus, A Luborzewski, C Opgen-Rhein, et al.
Pharmacopsychiatry
|
December 13, 2005
Electroconvulsive monotherapy in the treatment of acute confusion psychosis. A case report
A H Neuhaus, J Katchanov, C Opgen-Rhein, et al.
International Clinical Psychopharmacology
|
December 17, 2004
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study
M C Jockers-Scherübl, A Bauer, F Godemann, et al.
Page
of 2